Share Price and Basic Stock Data
Last Updated: December 5, 2025, 4:14 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Omkar Speciality Chemicals Ltd operates within the specialty chemicals sector, focusing on a niche market segment. The company’s stock price stood at ₹5.14 with a market capitalization of ₹10.7 Cr. Analyzing revenue trends, Omkar reported a significant decline in sales from ₹107 Cr in March 2011 to ₹19 Cr for the trailing twelve months (TTM). The most recent quarterly sales figures also reflect this downward trajectory, with June 2022 sales at ₹3.74 Cr, down from ₹10.70 Cr in June 2019. This contraction indicates challenges in maintaining revenue streams, exacerbated by fluctuating market demand and operational efficiency. The company has experienced volatility in its quarterly sales, with a peak of ₹18.97 Cr in September 2019 followed by a drastic dip to ₹5.14 Cr in June 2020, suggesting inconsistent operational performance and possibly market positioning issues.
Profitability and Efficiency Metrics
Profitability metrics for Omkar Speciality Chemicals Ltd have shown alarming trends, with a net profit of -₹13 Cr as of March 2022 and a trailing twelve months (TTM) loss of -₹13 Cr. The operating profit margin (OPM) stood at -25.40%, highlighting inefficiencies in managing operational costs relative to sales. Historical data demonstrates a pattern of negative operating profits, particularly with OPM declining significantly from 20% in March 2011 to -32% TTM. The company’s interest coverage ratio (ICR) of 4.04x indicates that it can cover its interest obligations, but the declining profitability raises concerns about sustainability. Furthermore, the cash conversion cycle (CCC) stood at -143 days, reflecting challenges in managing receivables and inventory effectively, which further complicates cash flow management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Omkar Speciality Chemicals reflects significant financial strain, with total borrowings of ₹226 Cr against reserves of -₹192 Cr. This negative reserve indicates accumulated losses over the years, significantly impacting the company’s equity position. The price-to-book value (P/BV) ratio stood at 1.84x, suggesting that the market values the company higher than its book value, but the negative reserves raise concerns about the underlying asset quality. The company’s long-term debt-to-equity ratio is not specified, but the total debt-to-equity ratio is critical in assessing financial leverage; the high level of borrowings without corresponding profitability poses a risk. Additionally, the return on capital employed (ROCE) at 10.5% indicates a suboptimal return from capital investments, necessitating a reassessment of operational strategies to enhance efficiency.
Shareholding Pattern and Investor Confidence
Investor confidence in Omkar Speciality Chemicals has been reflected in its shareholding pattern. Promoters hold 14.71% of the shares, a substantial drop from previous years when they held over 27%, indicating a potential lack of confidence in management’s direction. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have minimal stakes at 0.06% and 0.01%, respectively, suggesting limited institutional interest. The public holds the majority at 85.22%, with a total of 19,430 shareholders. This high public ownership alongside low institutional investment could result in volatility in stock price, particularly if market sentiment shifts. The declining promoter stake could further impact the stock’s attractiveness, as investor confidence often correlates with management’s commitment to the company’s growth.
Outlook, Risks, and Final Insight
Looking ahead, Omkar Speciality Chemicals faces multiple risks, including persistent operational inefficiencies and a challenging market environment. The negative reserve position and substantial borrowings signal potential liquidity issues, while the declining sales trend raises concerns about future revenue generation. Additionally, the company must navigate competitive pressures within the specialty chemicals sector, which may require strategic pivots to regain market share. However, if Omkar can effectively streamline operations, improve profitability, and restore investor confidence, there exists a potential for recovery. Strengthening operational management and exploring new market opportunities could enhance its financial performance. In summary, while the company has significant hurdles to overcome, strategic adjustments may foster a turnaround, contingent on the effective execution of its operational strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Omkar Speciality Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 403 Cr. | 43.9 | 86.5/42.2 | 25.1 | 20.5 | 0.91 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 32.6 Cr. | 66.5 | 103/56.0 | 15.6 | 89.6 | 1.50 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 47.4 Cr. | 696 | 988/600 | 21.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,567 Cr. | 78.7 | 111/74.5 | 23.6 | 22.0 | 0.64 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 652 Cr. | 262 | 453/241 | 23.4 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,767.68 Cr | 717.57 | 62.44 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.70 | 18.97 | 14.43 | 12.79 | 5.14 | 16.86 | 12.16 | 10.97 | 7.36 | 4.23 | 6.34 | 5.05 | 3.74 |
| Expenses | 10.31 | 17.88 | 14.10 | 14.83 | 4.86 | 13.80 | 9.20 | 10.78 | 7.76 | 6.55 | 6.21 | 8.16 | 4.69 |
| Operating Profit | 0.39 | 1.09 | 0.33 | -2.04 | 0.28 | 3.06 | 2.96 | 0.19 | -0.40 | -2.32 | 0.13 | -3.11 | -0.95 |
| OPM % | 3.64% | 5.75% | 2.29% | -15.95% | 5.45% | 18.15% | 24.34% | 1.73% | -5.43% | -54.85% | 2.05% | -61.58% | -25.40% |
| Other Income | 0.31 | 0.04 | 0.01 | 0.08 | 1.01 | 0.07 | 0.55 | 4.16 | 0.02 | 0.72 | 0.01 | 0.21 | 0.12 |
| Interest | 1.15 | 1.24 | 1.47 | 1.08 | 1.25 | 1.59 | 1.52 | 1.21 | 1.43 | 1.49 | 1.57 | 1.58 | 1.69 |
| Depreciation | 1.69 | 1.66 | 1.98 | 1.25 | 1.03 | 0.98 | 0.98 | 0.57 | 0.47 | 0.47 | 0.40 | 0.44 | 0.39 |
| Profit before tax | -2.14 | -1.77 | -3.11 | -4.29 | -0.99 | 0.56 | 1.01 | 2.57 | -2.28 | -3.56 | -1.83 | -4.92 | -2.91 |
| Tax % | 1.40% | 67.23% | 31.51% | 26.11% | 34.34% | 71.43% | 39.60% | -0.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -2.17 | -2.96 | -4.09 | -5.42 | -1.34 | 0.16 | 0.61 | 2.58 | -2.28 | -3.56 | -1.84 | -4.92 | -2.90 |
| EPS in Rs | -1.05 | -1.44 | -1.99 | -2.63 | -0.65 | 0.08 | 0.30 | 1.25 | -1.11 | -1.73 | -0.89 | -2.39 | -1.41 |
Last Updated: March 3, 2025, 2:32 pm
Below is a detailed analysis of the quarterly data for Omkar Speciality Chemicals Ltd based on the most recent figures (Jun 2022) and their trends compared to the previous period:
- For Sales, as of Jun 2022, the value is 3.74 Cr.. The value appears to be declining and may need further review. It has decreased from 5.05 Cr. (Mar 2022) to 3.74 Cr., marking a decrease of 1.31 Cr..
- For Expenses, as of Jun 2022, the value is 4.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.16 Cr. (Mar 2022) to 4.69 Cr., marking a decrease of 3.47 Cr..
- For Operating Profit, as of Jun 2022, the value is -0.95 Cr.. The value appears strong and on an upward trend. It has increased from -3.11 Cr. (Mar 2022) to -0.95 Cr., marking an increase of 2.16 Cr..
- For OPM %, as of Jun 2022, the value is -25.40%. The value appears strong and on an upward trend. It has increased from -61.58% (Mar 2022) to -25.40%, marking an increase of 36.18%.
- For Other Income, as of Jun 2022, the value is 0.12 Cr.. The value appears to be declining and may need further review. It has decreased from 0.21 Cr. (Mar 2022) to 0.12 Cr., marking a decrease of 0.09 Cr..
- For Interest, as of Jun 2022, the value is 1.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.58 Cr. (Mar 2022) to 1.69 Cr., marking an increase of 0.11 Cr..
- For Depreciation, as of Jun 2022, the value is 0.39 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.44 Cr. (Mar 2022) to 0.39 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2022, the value is -2.91 Cr.. The value appears strong and on an upward trend. It has increased from -4.92 Cr. (Mar 2022) to -2.91 Cr., marking an increase of 2.01 Cr..
- For Tax %, as of Jun 2022, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 0.00%.
- For Net Profit, as of Jun 2022, the value is -2.90 Cr.. The value appears strong and on an upward trend. It has increased from -4.92 Cr. (Mar 2022) to -2.90 Cr., marking an increase of 2.02 Cr..
- For EPS in Rs, as of Jun 2022, the value is -1.41. The value appears strong and on an upward trend. It has increased from -2.39 (Mar 2022) to -1.41, marking an increase of 0.98.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:44 am
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 107 | 167 | 202 | 210 | 193 | 319 | 317 | 198 | 43 | 57 | 45 | 23 | 19 |
| Expenses | 85 | 134 | 165 | 177 | 164 | 274 | 259 | 241 | 44 | 57 | 38 | 29 | 26 |
| Operating Profit | 21 | 33 | 36 | 33 | 29 | 45 | 57 | -43 | -1 | -0 | 7 | -6 | -6 |
| OPM % | 20% | 20% | 18% | 16% | 15% | 14% | 18% | -22% | -3% | -0% | 16% | -25% | -32% |
| Other Income | 1 | 4 | 6 | 6 | 5 | 9 | -161 | -49 | 12 | 0 | 5 | 1 | 1 |
| Interest | 5 | 8 | 7 | 12 | 11 | 17 | 22 | 26 | 15 | 5 | 6 | 6 | 6 |
| Depreciation | 2 | 6 | 6 | 6 | 2 | 4 | 11 | 8 | 8 | 7 | 4 | 2 | 2 |
| Profit before tax | 15 | 23 | 29 | 21 | 20 | 33 | -137 | -127 | -12 | -11 | 3 | -13 | -13 |
| Tax % | 31% | 29% | 28% | 30% | 12% | 33% | -20% | -18% | 46% | 29% | 36% | -0% | |
| Net Profit | 10 | 16 | 21 | 15 | 18 | 22 | -109 | -104 | -17 | -15 | 2 | -13 | -13 |
| EPS in Rs | 5.17 | 8.39 | 10.61 | 7.45 | 8.70 | 10.78 | -53.09 | -50.47 | -8.19 | -7.10 | 0.98 | -6.12 | -6.42 |
| Dividend Payout % | 19% | 15% | 14% | 20% | 17% | 14% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2011-2012 | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 60.00% | 31.25% | -28.57% | 20.00% | 22.22% | -595.45% | 4.59% | 83.65% | 11.76% | 113.33% | -750.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -28.75% | -59.82% | 48.57% | 2.22% | -617.68% | 600.04% | 79.07% | -71.89% | 101.57% | -863.33% |
Omkar Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2011-2012 to 2021-2022.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -41% |
| 3 Years: | -19% |
| TTM: | -59% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| TTM: | -345% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -22% |
| 5 Years: | -3% |
| 3 Years: | -33% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 11:55 am
Balance Sheet
Last Updated: April 13, 2025, 3:05 pm
| Month | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 73 | 86 | 107 | 118 | 142 | 161 | -23 | -146 | -169 | -183 | -179 | -192 |
| Borrowings | 45 | 78 | 118 | 154 | 176 | 186 | 181 | 233 | 230 | 233 | 228 | 226 |
| Other Liabilities | 35 | 33 | 38 | 50 | 50 | 80 | 129 | 28 | 26 | 26 | 17 | 18 |
| Total Liabilities | 172 | 217 | 283 | 342 | 389 | 447 | 307 | 136 | 107 | 97 | 86 | 72 |
| Fixed Assets | 21 | 36 | 44 | 43 | 68 | 78 | 83 | 76 | 68 | 53 | 28 | 26 |
| CWIP | 18 | 31 | 40 | 69 | 107 | 113 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 2 | 11 | 14 | 14 | 14 | 0 | 11 | 0 | 0 | 1 | 0 |
| Other Assets | 133 | 148 | 187 | 217 | 199 | 242 | 224 | 49 | 38 | 44 | 58 | 46 |
| Total Assets | 172 | 217 | 283 | 342 | 389 | 447 | 307 | 136 | 107 | 97 | 86 | 72 |
Below is a detailed analysis of the balance sheet data for Omkar Speciality Chemicals Ltd based on the most recent figures (Mar 2022) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2022, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2021) which recorded 21.00 Cr..
- For Reserves, as of Mar 2022, the value is -192.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -179.00 Cr. (Mar 2021) to -192.00 Cr., marking a decline of 13.00 Cr..
- For Borrowings, as of Mar 2022, the value is 226.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 228.00 Cr. (Mar 2021) to 226.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Mar 2022, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2021) to 18.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2022, the value is 72.00 Cr.. The value appears to be improving (decreasing). It has decreased from 86.00 Cr. (Mar 2021) to 72.00 Cr., marking a decrease of 14.00 Cr..
- For Fixed Assets, as of Mar 2022, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2021) to 26.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Mar 2022, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2021) which recorded 0.00 Cr..
- For Investments, as of Mar 2022, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2021) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Mar 2022, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2021) to 46.00 Cr., marking a decrease of 12.00 Cr..
- For Total Assets, as of Mar 2022, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2021) to 72.00 Cr., marking a decrease of 14.00 Cr..
However, the Borrowings (226.00 Cr.) are higher than the Reserves (-192.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -24.00 | -45.00 | -82.00 | -121.00 | -147.00 | -141.00 | -124.00 | -276.00 | -231.00 | -233.00 | -221.00 | -232.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93 | 84 | 111 | 148 | 129 | 117 | 90 | 19 | 74 | 30 | 111 | 33 |
| Inventory Days | 147 | 168 | 170 | 156 | 149 | 99 | 110 | 8 | 37 | 31 | 18 | 40 |
| Days Payable | 106 | 81 | 73 | 94 | 96 | 81 | 184 | 32 | 259 | 148 | 139 | 215 |
| Cash Conversion Cycle | 135 | 172 | 209 | 210 | 181 | 135 | 16 | -5 | -147 | -86 | -10 | -143 |
| Working Capital Days | 68 | 5 | 26 | -10 | -89 | 38 | -81 | -296 | -1,361 | -1,002 | -1,065 | -3,296 |
| ROCE % | 22% | 19% | 17% | 12% | 10% | 14% | 18% | -34% | -8% | -8% | 7% | -11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.88 | 12.03 | 6.91 | 10.47 | 8.15 |
| Diluted EPS (Rs.) | 14.88 | 12.03 | 6.59 | 10.46 | 8.15 |
| Cash EPS (Rs.) | 19.26 | 16.82 | 13.05 | 13.88 | 11.03 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 94.99 | 81.92 | 69.91 | 64.74 | 53.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 94.99 | 81.92 | 69.91 | 64.74 | 53.71 |
| Revenue From Operations / Share (Rs.) | 200.90 | 128.84 | 122.42 | 107.85 | 85.06 |
| PBDIT / Share (Rs.) | 39.96 | 25.79 | 23.53 | 22.53 | 18.53 |
| PBIT / Share (Rs.) | 35.58 | 20.77 | 17.39 | 19.12 | 15.65 |
| PBT / Share (Rs.) | 25.45 | 13.73 | 10.04 | 15.29 | 11.52 |
| Net Profit / Share (Rs.) | 14.88 | 11.80 | 6.91 | 10.47 | 8.15 |
| NP After MI And SOA / Share (Rs.) | 14.88 | 11.80 | 6.91 | 10.47 | 8.15 |
| PBDIT Margin (%) | 19.89 | 20.01 | 19.22 | 20.88 | 21.78 |
| PBIT Margin (%) | 17.70 | 16.11 | 14.20 | 17.72 | 18.39 |
| PBT Margin (%) | 12.66 | 10.65 | 8.20 | 14.17 | 13.54 |
| Net Profit Margin (%) | 7.40 | 9.15 | 5.64 | 9.71 | 9.58 |
| NP After MI And SOA Margin (%) | 7.40 | 9.15 | 5.64 | 9.71 | 9.58 |
| Return on Networth / Equity (%) | 15.66 | 14.40 | 9.88 | 16.17 | 15.17 |
| Return on Capital Employeed (%) | 24.08 | 18.45 | 16.75 | 20.38 | 23.00 |
| Return On Assets (%) | 5.25 | 5.06 | 3.36 | 6.24 | 6.73 |
| Long Term Debt / Equity (X) | 0.48 | 0.35 | 0.47 | 0.42 | 0.24 |
| Total Debt / Equity (X) | 1.06 | 1.19 | 1.39 | 1.14 | 0.90 |
| Asset Turnover Ratio (%) | 0.64 | 0.48 | 0.62 | 0.77 | 0.85 |
| Current Ratio (X) | 0.97 | 0.83 | 1.08 | 1.32 | 1.33 |
| Quick Ratio (X) | 0.61 | 0.47 | 0.65 | 0.81 | 0.82 |
| Inventory Turnover Ratio (X) | 2.22 | 1.49 | 1.38 | 2.05 | 2.60 |
| Dividend Payout Ratio (NP) (%) | 10.08 | 12.71 | 21.71 | 14.32 | 15.33 |
| Dividend Payout Ratio (CP) (%) | 7.78 | 8.91 | 11.49 | 10.80 | 11.32 |
| Earning Retention Ratio (%) | 89.92 | 87.29 | 78.29 | 85.68 | 84.67 |
| Cash Earning Retention Ratio (%) | 92.22 | 91.09 | 88.51 | 89.20 | 88.68 |
| Interest Coverage Ratio (X) | 4.04 | 3.66 | 3.22 | 5.88 | 4.49 |
| Interest Coverage Ratio (Post Tax) (X) | 2.52 | 2.68 | 1.95 | 3.73 | 2.98 |
| Enterprise Value (Cr.) | 556.39 | 517.22 | 461.39 | 345.22 | 178.59 |
| EV / Net Operating Revenue (X) | 1.35 | 1.95 | 1.92 | 1.63 | 1.07 |
| EV / EBITDA (X) | 6.77 | 9.75 | 9.99 | 7.81 | 4.91 |
| MarketCap / Net Operating Revenue (X) | 0.86 | 1.25 | 1.20 | 1.06 | 0.69 |
| Retention Ratios (%) | 89.91 | 87.28 | 78.28 | 85.67 | 84.66 |
| Price / BV (X) | 1.84 | 1.97 | 2.10 | 1.77 | 1.10 |
| Price / Net Operating Revenue (X) | 0.86 | 1.25 | 1.20 | 1.06 | 0.69 |
| EarningsYield | 0.08 | 0.07 | 0.04 | 0.09 | 0.13 |
After reviewing the key financial ratios for Omkar Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 12.03 (Mar 15) to 14.88, marking an increase of 2.85.
- For Diluted EPS (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 12.03 (Mar 15) to 14.88, marking an increase of 2.85.
- For Cash EPS (Rs.), as of Mar 16, the value is 19.26. This value is within the healthy range. It has increased from 16.82 (Mar 15) to 19.26, marking an increase of 2.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 94.99. It has increased from 81.92 (Mar 15) to 94.99, marking an increase of 13.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 94.99. It has increased from 81.92 (Mar 15) to 94.99, marking an increase of 13.07.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 200.90. It has increased from 128.84 (Mar 15) to 200.90, marking an increase of 72.06.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 39.96. This value is within the healthy range. It has increased from 25.79 (Mar 15) to 39.96, marking an increase of 14.17.
- For PBIT / Share (Rs.), as of Mar 16, the value is 35.58. This value is within the healthy range. It has increased from 20.77 (Mar 15) to 35.58, marking an increase of 14.81.
- For PBT / Share (Rs.), as of Mar 16, the value is 25.45. This value is within the healthy range. It has increased from 13.73 (Mar 15) to 25.45, marking an increase of 11.72.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 11.80 (Mar 15) to 14.88, marking an increase of 3.08.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 11.80 (Mar 15) to 14.88, marking an increase of 3.08.
- For PBDIT Margin (%), as of Mar 16, the value is 19.89. This value is within the healthy range. It has decreased from 20.01 (Mar 15) to 19.89, marking a decrease of 0.12.
- For PBIT Margin (%), as of Mar 16, the value is 17.70. This value is within the healthy range. It has increased from 16.11 (Mar 15) to 17.70, marking an increase of 1.59.
- For PBT Margin (%), as of Mar 16, the value is 12.66. This value is within the healthy range. It has increased from 10.65 (Mar 15) to 12.66, marking an increase of 2.01.
- For Net Profit Margin (%), as of Mar 16, the value is 7.40. This value is within the healthy range. It has decreased from 9.15 (Mar 15) to 7.40, marking a decrease of 1.75.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 7.40. This value is below the healthy minimum of 8. It has decreased from 9.15 (Mar 15) to 7.40, marking a decrease of 1.75.
- For Return on Networth / Equity (%), as of Mar 16, the value is 15.66. This value is within the healthy range. It has increased from 14.40 (Mar 15) to 15.66, marking an increase of 1.26.
- For Return on Capital Employeed (%), as of Mar 16, the value is 24.08. This value is within the healthy range. It has increased from 18.45 (Mar 15) to 24.08, marking an increase of 5.63.
- For Return On Assets (%), as of Mar 16, the value is 5.25. This value is within the healthy range. It has increased from 5.06 (Mar 15) to 5.25, marking an increase of 0.19.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.48. This value is within the healthy range. It has increased from 0.35 (Mar 15) to 0.48, marking an increase of 0.13.
- For Total Debt / Equity (X), as of Mar 16, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.19 (Mar 15) to 1.06, marking a decrease of 0.13.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.64. It has increased from 0.48 (Mar 15) to 0.64, marking an increase of 0.16.
- For Current Ratio (X), as of Mar 16, the value is 0.97. This value is below the healthy minimum of 1.5. It has increased from 0.83 (Mar 15) to 0.97, marking an increase of 0.14.
- For Quick Ratio (X), as of Mar 16, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 15) to 0.61, marking an increase of 0.14.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 2.22. This value is below the healthy minimum of 4. It has increased from 1.49 (Mar 15) to 2.22, marking an increase of 0.73.
- For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 10.08. This value is below the healthy minimum of 20. It has decreased from 12.71 (Mar 15) to 10.08, marking a decrease of 2.63.
- For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 7.78. This value is below the healthy minimum of 20. It has decreased from 8.91 (Mar 15) to 7.78, marking a decrease of 1.13.
- For Earning Retention Ratio (%), as of Mar 16, the value is 89.92. This value exceeds the healthy maximum of 70. It has increased from 87.29 (Mar 15) to 89.92, marking an increase of 2.63.
- For Cash Earning Retention Ratio (%), as of Mar 16, the value is 92.22. This value exceeds the healthy maximum of 70. It has increased from 91.09 (Mar 15) to 92.22, marking an increase of 1.13.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 4.04. This value is within the healthy range. It has increased from 3.66 (Mar 15) to 4.04, marking an increase of 0.38.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 2.52. This value is below the healthy minimum of 3. It has decreased from 2.68 (Mar 15) to 2.52, marking a decrease of 0.16.
- For Enterprise Value (Cr.), as of Mar 16, the value is 556.39. It has increased from 517.22 (Mar 15) to 556.39, marking an increase of 39.17.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.35. This value is within the healthy range. It has decreased from 1.95 (Mar 15) to 1.35, marking a decrease of 0.60.
- For EV / EBITDA (X), as of Mar 16, the value is 6.77. This value is within the healthy range. It has decreased from 9.75 (Mar 15) to 6.77, marking a decrease of 2.98.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 15) to 0.86, marking a decrease of 0.39.
- For Retention Ratios (%), as of Mar 16, the value is 89.91. This value exceeds the healthy maximum of 70. It has increased from 87.28 (Mar 15) to 89.91, marking an increase of 2.63.
- For Price / BV (X), as of Mar 16, the value is 1.84. This value is within the healthy range. It has decreased from 1.97 (Mar 15) to 1.84, marking a decrease of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 15) to 0.86, marking a decrease of 0.39.
- For EarningsYield, as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 15) to 0.08, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Omkar Speciality Chemicals Ltd:
- Net Profit Margin: 7.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.08% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.66% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.52
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 62.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.4%
Fundamental Analysis of Omkar Speciality Chemicals Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Mahalasa Narayani, Thane Maharashtra 421503 | info@omkarchemicals.com http://www.omkarchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pravin S Herlekar | Chairman & Managing Director |
| Mr. Subhash Ambatkar | Executive Director |
| Mrs. Sanjivani S Patare | Independent Director |
| Ms. Archana Dakhale | Independent Director |
| Mr. Kannan Thevar | Non Exe.Non Ind.Director |
Omkar Speciality Chemicals Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹6.81 |
| Previous Day | ₹6.49 |
FAQ
What is the intrinsic value of Omkar Speciality Chemicals Ltd?
Omkar Speciality Chemicals Ltd's intrinsic value (as of 04 December 2025) is 152.39 which is 2941.72% higher the current market price of 5.01, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 10.3 Cr. market cap, FY2025-2026 high/low of 9.99/4.90, reserves of ₹-192 Cr, and liabilities of 72 Cr.
What is the Market Cap of Omkar Speciality Chemicals Ltd?
The Market Cap of Omkar Speciality Chemicals Ltd is 10.3 Cr..
What is the current Stock Price of Omkar Speciality Chemicals Ltd as on 04 December 2025?
The current stock price of Omkar Speciality Chemicals Ltd as on 04 December 2025 is 5.01.
What is the High / Low of Omkar Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Omkar Speciality Chemicals Ltd stocks is 9.99/4.90.
What is the Stock P/E of Omkar Speciality Chemicals Ltd?
The Stock P/E of Omkar Speciality Chemicals Ltd is .
What is the Book Value of Omkar Speciality Chemicals Ltd?
The Book Value of Omkar Speciality Chemicals Ltd is 83.0.
What is the Dividend Yield of Omkar Speciality Chemicals Ltd?
The Dividend Yield of Omkar Speciality Chemicals Ltd is 0.00 %.
What is the ROCE of Omkar Speciality Chemicals Ltd?
The ROCE of Omkar Speciality Chemicals Ltd is 10.5 %.
What is the ROE of Omkar Speciality Chemicals Ltd?
The ROE of Omkar Speciality Chemicals Ltd is %.
What is the Face Value of Omkar Speciality Chemicals Ltd?
The Face Value of Omkar Speciality Chemicals Ltd is 10.0.